机构地区:[1]上海交通大学医学院附属瑞金医院感染科,200025
出 处:《中华传染病杂志》2010年第8期473-479,共7页Chinese Journal of Infectious Diseases
基 金:国家科技部十一五重大传染病专项(2008ZX10002-005、2008ZX10002007、2008ZX09312-007);国家自然科学基金项目(30872252);上海市科委基础研究重点项目(08JC1415300)
摘 要:目的 探讨乙型肝炎患者外周血单个核细胞(PBMC)中微小RNA(miRNA)和细胞因子的变化及其与炎性反应的相互关系.方法 收集健康对照者17例,急性乙型肝炎发作期、病毒清除期和恢复期患者各20例,慢性乙型肝炎轻度、中度和重度患者各20例和乙型肝炎后肝硬化患者20例.分离PBMC,采用反转录-荧光定量PCR方法检测miRNA146、miRNA155、miRNA181、IFN-α、IFN-β、IFN诱导基因54(ISG54)、IFN调节因子5(IRF5)的表达.多组间比较采用单因素方差分析.结果 急性乙型肝炎患者PBMC中miRNA155的表达水平在急性发作期(2.386±1.835)较高,明显高于健康对照组(1.498±1.276),差异有统计学意义(F=1.137,P=0.045),随疾病进入发作期、病毒清除期(1.633±2.291)、恢复期(0.642±0.836),其表达逐渐降低(F=2.122,P=0.022).同时IFN-α、IFN-β随急性发作期(7.059±9.594、4.767±6.725)、病毒清除期(2.216±2.148、1.750±1.403)和恢复期(0.642±0.836、1.201±0.779)其表达也逐渐降低(F=1.880,P=0.038;F=1.835,P=0.048).相关性分析发现,miRNA155与IFN-α、IFN-β均具有良好的正相关性(r=0.483,P=0.004;r=0.660,P=0.0002).在急性HBV感染患者中,miRNA155的表达与ALT、Tbil均呈正相关(r=0.342,P=0.006;r=0.322,P=0.011),但与血清HBV DNA载量无相关性.miRNA181在HBV感染者PBMC中的表达,除急性乙型肝炎恢复期(1.873±0.998)外,均高于健康对照组(1.307±0.935)(F=2.072,P=0.045),但HBV感染各组间差异无统计学意义.miRNA146的表达水平变化不明显.结论 在HBV感染过程中,miRNAs参与了宿主的抗HBV免疫反应,并与细胞因子表达相关.Objective To investigate the expressions of microRNAs (miRNA) and cytokines in the peripheral blood mononuclear cells (PBMCs) of patients with hepatitis B virus (HBV) infection and analyze their relationship with inflammation. Methods PBMCs were collected from acute hapatitis B (AHB) patients of 3 groups, including acute episode, virus clearance, recover period, and chronic hepatitis B (CHB) of mild, medium, severe type, and HBV-related liver cirrhosis. Each group included 20 patients, and 17 healthy donors were as control. Reverse transcription-polymerase chain reaction was used to measure miRNA146, miRNA155, miRNA181, interferon (IFN)-α, IFN-β,interferon induced gene 54 (ISG54) and interferon regulate factor 5 (IRF5). Comparisons among groups were done by one factor analysis of variance. Results The expression of miRNA155 was high in acute episode of AHB (2. 386± 1. 835), and higher than healthy control (1. 498± 1. 276) (F=1. 137,P-=0. 045), while reduced in acute episode, virus clearance (1. 633±2. 291), and recover period (0. 642±0. 836) (F=2. 122,P=0. 022). The expressions of IFN-α and IFN-β in AHB reduced in acute episode, virus clearance and recover period ( F = 1. 880, P = 0. 038 ; F= 1. 835, P = 0. 048).The expression of miRNA155 in AHB is closely correlated with IFN-α and IFN-β (r = 0. 483, P=0. 004; r= 0. 660, P= 0. 0002, respectively). In addition, in HBV infectious patients, the expression of miRNA155 was correlated with alanine transarninase (ALT), serum bilirubin (TBil) (r=0. 342,P=0. 006; r=0. 322, P= 0. 011, respectively), but not with HBV DNA load. Compared with healthy control (1. 307+ 0. 935), miRNA181 was higher in patients with HBV infection (F= 2. 072, P=0. 045) except AHB in recover period (1. 873±0. 998). There was no statistical difference in the miRNA146 expression between various groups. Conclusions The exprossion of miRNAs might be involved in the host anti-HBV immune response during H
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...